| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0306-4522(99)00402-9 |
| P8608 | Fatcat ID | release_4s2bqthlkjfsvjktkuent2pytm |
| P698 | PubMed publication ID | 10619478 |
| P2093 | author name string | K Yoshikawa | |
| H Ito | |||
| T Uchida | |||
| K Kajiwara | |||
| M Ideguchi | |||
| P2860 | cites work | In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector | Q29547503 |
| Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
| T-cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. | Q33658811 | ||
| Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation | Q34591923 | ||
| Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression | Q34615481 | ||
| Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy | Q35232341 | ||
| Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver | Q35559973 | ||
| Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses | Q35837026 | ||
| The immunogenicity of intracerebral virus infection depends on anatomical site. | Q35874762 | ||
| CTLA-4 is a second receptor for the B cell activation antigen B7 | Q36230356 | ||
| Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. | Q36310768 | ||
| Activated B cells express receptors for, and proliferate in response to, pure interleukin 2. | Q36349546 | ||
| The immune response to intracerebral neural grafts | Q36705265 | ||
| A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia | Q37412249 | ||
| Monoclonal xenogeneic antibodies to murine cell surface antigens: identification of novel leukocyte differentiation antigens | Q39510598 | ||
| The T cell receptor | Q39682077 | ||
| Macrophages and inflammation in the central nervous system | Q40489629 | ||
| Interactions between lymphocytes, macrophages, and central nervous system cells | Q40701575 | ||
| Persistent transgene expression in the hypothalamus following stereotaxic delivery of a recombinant adenovirus: suppression of the immune response with cyclosporin | Q41155846 | ||
| Neuronal cells are deficient in loading peptides onto MHC class I molecules | Q41620648 | ||
| MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. | Q41664847 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans | Q42476540 | ||
| Interleukin-1 mediates a rapid inflammatory response after injection of adenoviral vectors into the brain. | Q42536199 | ||
| Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli | Q42768169 | ||
| Assessment of recombinant adenoviral vectors for hepatic gene therapy | Q43425277 | ||
| Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. | Q43535009 | ||
| Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice | Q43836200 | ||
| Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study | Q44202627 | ||
| Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer | Q44747875 | ||
| Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenovirus-mediated in vivo gene transfer to mouse synovium. | Q44809129 | ||
| Immunological instability of persistent adenovirus vectors in the brain: peripheral exposure to vector leads to renewed inflammation, reduced gene expression, and demyelination | Q44907561 | ||
| Immune responses to adenoviral vectors during gene transfer in the brain | Q45269702 | ||
| Gene therapy of cystic fibrosis lung disease using E1 deleted adenoviruses: a phase I trial | Q45866236 | ||
| Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration | Q45866667 | ||
| Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. | Q45867442 | ||
| Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. | Q45870000 | ||
| Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation | Q45872564 | ||
| An adenovirus vector for gene transfer into neurons and glia in the brain | Q45874317 | ||
| Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors | Q45875094 | ||
| Ex vivo adenovirus-mediated gene transfer and immunomodulatory protein production in human cornea. | Q45883343 | ||
| Long-term gene therapy in the CNS: reversal of hypothalamic diabetes insipidus in the Brattleboro rat by using an adenovirus expressing arginine vasopressin. | Q45884569 | ||
| Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis. | Q45890414 | ||
| Reactive cell proliferation and microglia following injury to the rat brain. | Q48146126 | ||
| A model system for in vivo gene transfer into the central nervous system using an adenoviral vector | Q48325479 | ||
| Suppression of inflammation by dexamethasone prolongs adenoviral vector-mediated transgene expression in the facial nucleus of the rat. | Q48348307 | ||
| Expression of a functional foreign gene in adult mammalian brain following in Vivo transfer via a herpes simplex virus type 1 defective viral vector | Q48675433 | ||
| A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. | Q54796003 | ||
| Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig | Q56908863 | ||
| Transfer of a foreign gene into the brain using adenovirus vectors | Q64377820 | ||
| A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5 | Q64379529 | ||
| Use of transient CD4 lymphocyte depletion to prolong transgene expression of E1-deleted adenoviral vectors | Q64382915 | ||
| "Sero-switch" adenovirus-mediated in vivo gene transfer: circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype | Q64383018 | ||
| Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector | Q64383065 | ||
| Adenovirus gene transfer causes inflammation in the brain | Q64383186 | ||
| A cell culture model for T lymphocyte clonal anergy | Q67299314 | ||
| Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis | Q71660966 | ||
| Demyelination in the central nervous system following a delayed-type hypersensitivity response to bacillus Calmette-Guérin | Q72244649 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 217-226 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Neuroscience | Q15708571 |
| P1476 | title | Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain | |
| P478 | volume | 95 |
| Q40839095 | Cell Therapy for Parkinson's Disease: A Translational Approach to Assess the Role of Local and Systemic Immunosuppression. |
| Q48913603 | Co-administration of adenovirus vector expressing CTLA4-Ig prolongs transgene expression in the brain of mice sensitized with adenovirus |
| Q33243196 | Co-expression of sCD40LIg and CTLA4Ig mediated by adenovirus prolonged mouse skin allograft survival |
| Q33674877 | GENE THERAPY FOR THE TREATMENT OF PITUITARY TUMORS |
| Q33904294 | Gene transfer into rat brain using adenoviral vectors. |
| Q36274402 | Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells. |
| Q40384077 | Transgenic expression of CTLA4-Ig by fetal pig neurons for xenotransplantation. |
Search more.